Outcome of Board meeting held on 13th August 2026

SUNLOC August L3,2026 sHL/SEC/2025 The BombaY Stock Exchange Limited The Calcutta Stock Exchange Ltd' 7, Lyons Range Listing DePartment, Kolkata'700 001 lndia 1st Floor, New Trading Ring, Rotunda Building, Phiroze JeeJeeBhoy Towers, Dalal Street' Fort Mumbai- 400 001. CompanY Code: 537253 Dear Sir, Sub. : Outcome of the 270th Board Meeting held on 13'08'2025' pursuant to Regulation 30 of the sEBl (LODR) Regulations' 201"5' we are pleased to inform', inter-alia the outcome of the Meeting of the Board of Directors of the company held on Thursday,AugustL3,?oz6,themeetingWasstartedal4.23p.m.andconcludedat 6.20 P.m. 1. Approved the un-Audited Financial Results (both standalone and consolidated) for the lst quarter of the Financial year 2026-27 ended on June 30' 2026' 2. Approved appointment of M/s. MUFG lntime lndia Private Limited (formerly M/s. Link lntime lndia Pvt. Ltd.), an agency to conduct Remote e-voting/e-voting and Video conferencing for ensuing tf,e 52nd Annual General Meeting to be held on MondaY, SePtembe r 28, 2026' 3.ApprovedappointmentofM/s.ATcs&Associates,PeerReviewedPracticing (lcsl Unique ldentification No. P2017RJ063900), Jaipur as Company Secretaries, scrutinizer for conducting e-voting for the 52nd Annual General Meeting' 4. Fixed Book closure period from 22.09.2026 to 28'09'2026 for the purpose of ensuing Annual General Meeting to be held on Monday, 28.09'2026 through VC/OAVM trom ttre registered office of the Company' New Delhi' 3r<i Floor Vijay Tower SahaPUr Jat Na',v Del'ri 11C049 * l lPagc Sunil Healthcare Limited VijayTower, 38E1252 - A, ShahpurJat, Panchsheel Park Commercial Complex, New Delhi-110049 (lNDlA) T: +9\ 17 49435555/OO E-mail; info@sunilhealthcare.com Web.: www.sunilhealthcare.com C I N No. : L243OZDLL97 3P1C189652 5. Fixed the date of ensuing Annual General Meeting to be held on Monday, 21.09.2026 at Registered office at38El252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049 through video conferencing/other Audio Visual Method and approved the Cut-off date for determining the entitlements of Members to attend and vote at AGM will be September 2t,2026. you are requested to take the above information in your record and oblige us. Thanking you, Yours sincerely, for I Healthcare 3rd Floor M;ay Tower Sahapur Jat Nerv Delhi 110049 Company Sec FCS-7736 Date: 13.08.2026 Place: New Delhi Encl.: a/a 2lP ge {, Unit No. 1704, lTth Floor, Singfri Co, World Trade Tower, (WTT), DNO Flyway, Sector 16, Noida 201 301 (lndia) &?&e rf*r'ed .A ceo ryn fasr fs T E + n9 e1 w ( d0 e1 lh20 i@) 2 s9 in7 g h00 lc0 o5 ., c o9 m2055 75996 www.singhico.com lndependent Auditor's Review Report on the Quarterly Unaudited Standalone Financial Results of the Gompany for the quarter ended June 30, 2026 pursuant to the Regulation 33 of the SEB! (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. To the Board of Directors of Sunil Healthcare Limibd We have reviewed the accompanying statement of unaudited standalone financial resuJts of Sunil Healthcare Limited (the Company') for the quarter ended June 30, 2026 (Statement"). This Statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility is to issue a report on this Statement based on our review. 2. This Stiatement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in lndian Accounting Standard 34 "lnterim Financial Reporting' ("lnd AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in lndia. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagement (SRE) 2410, "Review of lnterim Financial lnformation Performed by the lndependent Auditor of the Entity" issued by the lnstitute of Chartered Accountants of lndia. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limiled primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement read with notes therein, prepared in accordance with the recognition and measurement principles laid down in the aforesaid lndian Accounting Standard and other accounting principles generally accepted in lndia, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Singhi & Co lr Chartered Accountants Firm Reg. No. 302049E !\.lo:DA /b-- DELiIi Bimal Kumar Sipani Partner Place: Noida (Delhi-NCR) Membership No.088926 Date: Augusl13,2026 UDI N: 26088926HD42WY7623 Page 1 of 1 3ffi;es : Kotkata, oelhi NcR, Mumbai, ch8nnai, Bengaluru, Pune & Raipur Unit No. 1704, lTth Floor, Singfii st, Co, World Trade Tower, (WTT), DND Flyway, Sector 16, Noida 201 301 (lndia) T +91 (0120) 297 0005,920s5 75996 tilft c rie;"cd /l,rc&d.rs* fam fs E newdelhi@singhico.com www.singhlco.com lndependent Auditor's Review Report on Quarterly Unaudited Consotidated Financial Results of the Company for the quarter ended June 30, 2026 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended To Board of Directors of Sunil Healthcare Limited 1 . We have reviewed the accompanying Statement of unaudited consolidated financial results of Sunil Healthcare Limited ('the Companyl tne earent') and its subsidiaries (the Parent and its subsidiaries together referred to as 'the Group") for the quarter ended June 30,2026, ("the Statement") being suibmitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. This Statement, which isthe responsibility of the Parent's Management and approved bythe Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in lndian Accounting Standard 34 "lnterim Financial Reporting'("lnd AS 34'), pr"""iiU"O under Section 1 33 of the Companies Act, 2013, and other accounting principles generally iccepted in lndia. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of lnterim Financial lnformation Performed by the lndependent RuIit6r of the Entity;, issued by the lnstitute of Chartered Accountants of lndia. A review of interim financial information consists oi making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in soJpe than an audii b6nducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI.under Regulation 33 (8) ot tne Seat llisting Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent aPPlicable. 4. The Statement includes the results of the following foreign subsidiaries: a) Sunil Healthcare Mexico Sa De C [Showing first 8,000 characters — download PDF for full document]